Pharmaceutical composition comprising: (a) a first pharmacologically active ingredient selected from the compound according to formula (I) and physiologically acceptable salts thereof ** Formula ** and (b) a second pharmacologically active ingredient that is a selected anticonvulsant between the group consisting of retigabine, lamotrigine, lacosamide, levetiracetam, carbamazepine, sultiamo, phenacemide, felbamate, topiramate, phenethuride, brivaracetam, selectracetam, zonisamide, stiripentol, beclamide, mexiletine, ralfinamide, methoxonabital, methylphenbital, meclothonabital, meclothonabital, meclothonabital, meclothonabital, meclothonabital, primalbital , phenytoin, valeric amino (diphenylhidantoin) acid, mefenitoin, phosphenytoin, parametadione, trimetadione, etadione, ethosuximide, fensuximide, mesuximide, clonazepam, lorazepam, diazepam, clobazam, oxcarbazepine, eslicarbazidapidamine, aminoprophyrinoxylamino, amino, progabide, thiagabine, and physiologically acceptable salts d and the sameComposición farmacéutica que comprende: (a) un primer ingrediente farmacológicamente activo seleccionado entre el compuesto de acuerdo con la fórmula (I) y sales fisiológicamente aceptables del mismo**Fórmula** y (b) un segundo ingrediente farmacológicamente activo que es un anticonvulsivo seleccionado entre el grupo consistente en retigabina, lamotrigina, lacosamida, levetiracetam, carbamazepina, sultiamo, fenacemida, felbamato, topiramato, feneturida, brivaracetam, selectracetam, zonisamida, estiripentol, beclamida, mexiletina, ralfinamida, metilfenobarbital, fenobarbital, primidona, barbexaclona, metarbital, etotoína, fenitoína, ácido amino(difenilhidantoin)valérico, mefenitoína, fosfenitoína, parametadiona, trimetadiona, etadiona, etosuximida, fensuximida, mesuximida, clonazepam, lorazepam, diazepam, clobazam, oxcarbazepina, eslicarbazepina, rufinamida, ácido valproico, valpromida, ácido γ- aminobutírico, progabida, tiagabina, y sales fisiológicamente aceptables de los mis
